The use of combination TNF-inhibitor-methotrexate therapy in people with rheumatoid arthritis was associated with a risk of heart attack that was reduced by 80 percent in comparison with those using methotrexate alone, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
In early inflammatory arthritis, higher rates of remission are achieved if treatment is started early with conventional therapies and patients are more closely followed, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
A potential new therapy called certolizumab pegol, when used in combination with methotrexate, may be safe and effective at treating active rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Being overweight can prevent sufferers of rheumatoid arthritis from going into remission, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Phase III testing shows that a potential new therapy called tocilizumab is safe and effective in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
Denosumab treatment every six months can reduce bone erosions in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.
People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. Researchers at Mayo Clinic have developed a simple approach to predict heart disease in these patients within ten years of their initial diagnosis of rheumatoid arthritis.
Three University of Alabama at Birmingham researchers have been awarded a combined $1.2 million to study the underlying causes of rheumatoid arthritis and to help find a cure. Two of the studies will explore the molecular development of rheumatoid arthritis. Another project will be to identify hereditary and biological differences between some patients, and whether genetics can aid arthritis care.
Officials with Baylor Research Institute and the Mount Sinai School of Medicine announced today that the institutions are collaborating to develop therapeutic cancer vaccines for patients with lymphoma and myeloma, both cancers that affect the immune system. Additionally, the researchers will investigate ways to better diagnose autoimmune disorders such as arthritis and lupus.
For patients suffering from osteoarthritis of the hip or knee, doing aerobic and stretching exercises in warm water can bring some relief from the pain and could improve daily function, a new review has found.
Many common ways of treating osteoarthritis of the knee have no scientific support, including popular dietary supplement ingredients, a common surgical procedure, and injected preparations.
Radiofrequency ablation, where heat energy destroys or stuns the nerves of a painful joint, is a developing therapy for chronic arthritis-related back pain. In the right situation, this approach may be welcome -- though usually not permanent -- relief, according to the October issue of Mayo Clinic Health Letter.
Used in conjunction with other treatment options, a support device may help you combat the discomfort of an arthritic knee.
On Wednesday, September 19, the American College of Rheumatology and the Arthritis Foundation will jointly brief members of Congress and their staffs about the devastating effects of arthritis and related rheumatic diseases. During the briefing, both organizations will request Congressional support of the "Arthritis Prevention, Control and Cure Act of 2007" (S.626/H.R. 1283).
Arthritis of the knee may be the first sign of a type of lung cancer that is hard to treat in heavy smokers, suggests research published ahead of print in the Annals of the Rheumatic Diseases.
Researchers recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination. Their findings open new avenues for developing therapies to treat such diseases as sepsis, diabetes, and rheumatoid arthritis.
If your rotator cuff shows excessive wear, this procedure may net you big gains in shoulder stability.
The American College of Rheumatology Research and Education Foundation (ACR REF) has selected 15 experienced researchers from leading institutions to receive an estimated $6 million from the Foundation's new "Within Our Reach: Finding a Cure for Rheumatoid Arthritis" campaign.
Preliminary research suggests that use of the anti-malarial drug hydroxychloroquine may help reduce the risk of the development of diabetes in patients with rheumatoid arthritis, according to a study in the July 11 issue of JAMA.
Researchers at the University of Kentucky have advanced research of a natural product found in an Indian medicinal plant that has shown effectiveness in blocking blood-vessel and tumor growth. The discovery may help lead to treatments for certain types of metastatic breast, prostate and colon cancers.
The American College of Rheumatology Research and Education Foundation (REF) today announced that Amgen Inc. and Wyeth Pharmaceuticals have committed more than $5.5 million to support programs designed by the REF to ensure that a highly trained workforce is available to provide clinical care to patients with rheumatic diseases.
Like their human owners, dogs are at risk of suffering broken bones, torn ligaments, arthritis and congenital diseases. Fortunately for both pet owner and pet, there are veterinarians who can treat these ailments and get pets back on their feet.
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that showed that the safety profile of ENBREL® (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.
A phenomenon called "referred pain" can cause discomfort in a part of your body that's healthy and far from the source of your distress.
A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy.
Rheumatology researchers have discovered that a well-known cell receptor sends a signal to dampen the immune system. While not having an immediate application to treating disease, the finding raises the possibility that physicians might eventually rein in overzealous human immune responses to protect transplant patients or treat autoimmune diseases such as lupus and rheumatoid arthritis.
For the better part of three decades, Sherrie Kossoudji has endeavored each day to manage the inflammation, chronic pain, tight joints and other types of physical strife caused by rheumatoid arthritis. Now 53, Kossoudji is trying to sort out what is a normal part of aging, and what is a facet of RA.
University of Saskatchewan health researcher John Gordon is working to develop a new anti-inflammatory drug that could ease the suffering of people with arthritis, inflammatory bowel disease, and cystic fibrosis, as well as reduce damage caused by heart attacks and strokes.
A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.
Bacteria that insert themselves inside key front-line immune cells in mice can trigger a strong immune response, says a new University of Michigan study published online in Immunity. The findings add to a new picture of the immune response that points the way to more effective vaccines and more precisely targeted drugs for some autoimmune diseases.
A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in high cardiovascular risk patients with osteoarthritis. The researchers compared combination treatments of low-dose aspirin with the drugs ibuprofen, naproxen and the cox-2 inhibitor lumiracoxib. They have found that high cardiovascular risk patients taking ibuprofen and aspirin combined are nine times more likely suffer a heart attack.
Contrary to widespread belief, total surgical replacement of arthritic shoulder joints carries no greater risk of complications than replacement of other major joints, a Johns Hopkins study suggests.
Association of Rheumatology Health Professionals offers audioconference on physical intimacy, sex and rheumatic disease.
Here are four tips for minimizing the aches and pains that come with aging bones, joints, and muscles.
Knee and hip implants don't last forever. The good news is, advancements in revision surgery can keep you mobile and independent longer.
Many patients who receive a bone marrow transplant will develop graft versus host disease. Now researchers at the U-M Comprehensive Cancer Center say a rheumatoid arthritis drug, when combined with traditional steroid medication, can eliminate GVHD in more than two-thirds of bone marrow transplant patients.
A report in the January issue of Nature magazine announces that one more step in understanding what may cause the body to attack itself in its war against autoimmune disease has been discovered by researchers at the Massachusetts Institute of Technology's Whitehead Institute, says the American Autoimmune Related Diseases Association (AARDA), a national nonprofit patient advocacy organization.
Low doses of steroids can inhibit joint damage when used in the early phase of rheumatoid arthritis, according to a new review of evidence.
Researchers identify the gene control circuitry that enables the body to prevent a wide range of autoimmune diseases.
It happens to all of us: joint pain from a lifetime of lifting, bending and normal wear and tear. Beyond medication, there are steps you can take to relieve stress while going about your daily activities. Here's what you can do, from a world leader in arthritis care.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right